Welcome to your ultimate radiology resouce


dr-razz.com keyword stats



Most current MSN search phrases:

behavior radiology
disease  

Early Breast Cancer Detection

Most women are familiar with mammography asscreening. DITI measures heat emitted from
our "gold standard" for breast cancerthe body and is accurate to 1/100th of a
screening. However, there are additionaldegree. DITI examines physiology, NOT
tools available that women can add to theirstructure. It is in this capacity that DITI
arsenal.can monitor breast HEALTH over time and alert
a patient or physician to a developing
One of the most effective tools in breastproblem; possibly before a lump can be seen
cancer screening is breast self-exam (BSE).on X-ray or palpated clinically. There are
However, BSE works best when women areno test limitations such as breast density.
appropriately trained in the procedure, andDITI is a non-invasive test that does not
then followed-up with annual clinical breastemit  radiation.
exams (CBE) from their physicians. In a 2000
University of Toronto study, approximatelyThe unique characteristics of cancer allow
20,000 women were screened for breast cancerDITI to detect breast cancer at an earlier
with BSE and annual CBE, and 20,000 werestage of growth. As cancer is developing, it
screened with BSE and mammograms. After morebuilds its own blood supply which is then
than 10 years, the BSE and annual CBEreflected as increased heat in that
reported 610 cases of invasive breast cancer,particular region of the breast. DITI has a
and 105 deaths. In the BSE and mammogramspecificity of 83%; which reflects a problem
group, there were 622 cases of invasivein its early stages of development not
breast cancer and 107 deaths. Withoutlate-stage cancer as in mammography. An
question, the first line of defense againstabnormal thermogram carries a 10-times
breast  cancer  begins  with  diligent  BSE.greater risk for cancer and a persistently
abnormal thermogram carries a 22-times
Other tools that are available to womengreater  risk  for  cancer.
include the AMAS (anti-malignan antibody
screen) test and the NMP Nuclear matrixClinical research studies continue to support
protein) test. Both these are blood teststhermography's role as an adjunctive tool in
that measure a certain protein in the bloodbreast cancer screening and the ONLY tool
that may indicate cancer. The AMAS test hasthat measures breast health over time. There
been around for several years while the NMPare now more than 800 publications on over
test has not been available until only300,000 women in clinical trials. A recent
recently. Clinical trials continue in thisfinding published in the American Journal of
area.Radiology in 2003 showed that thermography
has 99% sensitivity in identifying breast
One additional tool that may detect an issuecancer with single examinations and limited
early is digital infrared thermal imaging orviews. Scientists concluded that a negative
DITI. In 1982, the FDA approved thermographythermogram is powerful evidence that cancer
as an adjunctive tool for breast canceris not present.



1 A B C D E 70 71 72 74 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 106 107 109 111 112